COVID-19 pandemic fuels largest continued backslide in vaccinations in three decades
On Jul. 15, 2022, The largest sustained decline in childhood vaccinations in approximately 30 years has been recorded…
Sanofi and Parkinson’s Foundation collaborated to advance availability of free genetic testing and counseling for people with Parkinson’s disease
On Jun. 1, 2021, Sanofi announced that Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus…
Dynavax and Serum Institute announced first participant dosed in trial evaluating Tdap vaccine adjuvanted with CpG 1018
On Feb. 3, 2021, Dynavax Technologies and Serum Institute of India announced that the first participant has been…
FDA approved expanded use of Sanofi’s Adacel Tdap vaccine for a second dose in people ages 10 through 64 years of age
On Jan. 14, 2019, Sanofi announced the FDA had approved the expanded use of Adacelï¾® (Tetanus Toxoid, Reduced…
FDA approved Vaxelis, a new combination DTaP-IPV-Hib-HepB vaccine for use in children 6 wks-4 yrs of age
On Dec. 26, 2018, Sanofi announced the U.S. Food and Drug Administration (FDA) had approved VAXELIS (Diphtheria and…
CDC published summary of previously published ACIP recommendations for prevention of tetanus, diphtheria, and pertussis in the U.S.
On Apr. 27, 2018, the Centers for Disease Control and Prevention (CDC) published a comprehensive summary of previously…
CDC published the 2017 US recommended immunization schedules for 0 through 18 years
On Feb. 10, 2017, the Advisory Committee on Immunization Practices (ACIP) approved the Recommended Immunization Schedule for Children…
FDA lowered age of licensure for Adacel vaccine administration from age 11 years to 10 years
On Apr. 1, 2014, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had expanded the approved…
Biotechnology | CDC | Life Science News | Non-Profit Research | Therapeutics | Vaccine | Women's Health
ACIP recommended a dose of Tdap vaccine during each pregnancy
On Feb. 22, 2013, the Advisory Committee on Immunization Practices (ACIP) recommended that unvaccinated pregnant women receive a…
FDA approved Boostrix to prevent tetanus, diphtheria, and pertussis in older people
On Jul. 8, 2011, the FDA approved Boostrix (Tdap, GlaxoSmithKline) to prevent tetanus, diphtheria, and pertussis in older…
FDA approved expanded indication for use of Boostrix Tdap vaccine in people ages 10-64 years
On Dec. 4, 2008, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus…
Biotechnology | FDA | Life Science News | Polio | Vaccine
FDA approved new DTaP-IPV vaccine (Kinrix) for use in children ages 4-6 years
On Jun. 24, 2008, the U.S. Food and Drug Administration (FDA) licensed a combined diphtheria and tetanus toxoid…
Biotechnology | FDA | Life Science News | Polio | Vaccine
FDA licensed Sanofi Pasteur’s new pediatric combination vaccine, Pentacel
On Jun. 23, 2008, Sanofi Pasteur announced the U.S. Food and Drug Administration had licensed Pentacel, Diphtheria and…
FDA approved the use of Sanofi Pasteur’s Tenivac tetanus and diphtheria toxoids
On Jun. 5, 2008, the FDA approved the use of Sanofi Pasteur’s Tenivac tetanus and diphtheria toxoids adsorbed…
FDA licensed a 2nd Tdap vaccine (Adacel by Sanofi Pasteur) for use in persons ages 11-64 years
On Jun. 9, 2005, the U.S. Food and Drug Administration (FDA) licensed a 2nd Tdap vaccine (Adacel by…
Cellular pertussis vaccine combined with adult formulation of tetanus and diphtheria licensed in persons 10-18 years of age
On May 3, 2005, the cellular pertussis vaccine combined with the adult formulation of tetanus and diphtheria (Tdap:…
Tetanus and diphtheria toxoids adsorbed for adult use, preservative-free, was licensed
On Mar. 24, 2004, the U.S. Food and Drug Administration (FDA) licensed tetanus and diphtheria toxoids adsorbed for…
Vaccine that combined diphtheria, tetanus, acellular pertussis, inactivated polio and hepatitis B antigens was licensed
On Dec. 13, 2002, the U.S. Food and Drug Administration (FDA) announced it had licensed a combined diphtheria…
Diphtheria and tetanus toxoids and acellular pertussis vaccine (Daptacel by Aventis Pasteur) was licensed
On May 14, 2002, the Food and Drug Administration (FDA) approved for use an additional combined diphtheria and…
Diphtheria and tetanus toxoids and acellular pertussis vaccine was licensed
On Dec. 9, 1999, the diphtheria and tetanus toxoids and acellular pertussis vaccine (Tripedia by Connaught) was licensed….
ACIP recommended DTaP vaccines for all five doses in the vaccination schedule
On Jan. 15. 1999, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Certiva by North American Vaccine) was licensed
On Jul. 29, 1998, the diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Certiva by North American…
Diphtheria and tetanus toxoids and acellular pertussis vaccine was licensed
On Dec. 30, 1996, the Food and Drug Administration (FDA) announced it had licensed three DTaP vaccines for…
Combination DTaP and Hib vaccine was licensed for the fourth dose in the DTaP and Hib series
On Sept. 27, 1996, the Food and Drug Administration (FDA) licensed a Haemophilus b Conjugate Vaccine (ActHIB) combined…
Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed was licensed
On Jul. 31, 1996, the diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Tripedia by Aventis Pasteur)…
The FDA approved use of a new haemophilus b conjugate vaccine for infants and children
On Mar. 30, 1993, the U.S. Food and Drug Administration (FDA) approved a new Haemophilus b conjugate vaccine,…
Diphtheria and tetanus toxoids and acellular pertussis vaccine licensed for use
On Aug. 21, 1992, the Food and Drug Administration (FDA) approved licensure of a second DTaP product, prepared…
Diphtheria and tetanus toxoids and acellular pertussis vaccine was licensed for use
On Dec. 17, 1991, the Diphtheria and tetanus toxoids and acellular pertussis vaccine (Acel-Imune by Lederle) was licensed…
The National Childhood Vaccine Injury Act of 1986 was enacted by Congress
In 1986, the National Childhood Vaccine Injury Act was enacted by Congress. The Department of Health and Human…
CDC | Infectious Disease | Life Science History | Measles | NIH | U.S. Congress | Vaccine
U.S. Dept. of Health, Education, and Welfare (HHS) announced nationwide Childhood Immunization Initiative
On Apr. 6, 1977, the Department of Health, Education, and Welfare (now Department of Health and Human Services)…